Trials / Not Yet Recruiting
Not Yet RecruitingNCT07215221
Implementation of TBI-RECOVER in Substance Use Treatment
Implementation of the Novel TBI-RECOVER Intervention in Substance Use Treatment: A Hybrid Type 2 Effectiveness-Implementation Pilot Trial
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 900 (estimated)
- Sponsor
- Ohio State University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this hybrid type 2 pilot trial is to understand the implementation and effectiveness of the TBI-RECOVER intervention model (e.g., brain injury screening, cognitive and behavioral challenges screening, and neurocognitive accommodations) on patient retention in outpatient substance use disorder treatment. We will evaluate whether an implementation strategy bundle (e.g., training/education, champions, audit \& feedback, facilitation) improves provider use and sustainability of the TBI-RECOVER intervention, and also whether the TBI-RECOVER intervention improves patient symptoms and treatment retention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | TBI-RECOVER | The TBI-RECOVER intervention model consists of three components: 1) a web-based brain injury and cognitive impairment screener using the Online Brain Injury Screening and Support System (OBISSS) of the National Association of State Head Injury Administrators, 2) brief education and information on traumatic brain injury and substance use disorders, and 3) neurocognitive accommodations, or compensatory strategies, for neurological impairment. |
| BEHAVIORAL | Control | The control condition includes a brief information and educational sheet on traumatic brain injury and substance use disorder, how these two conditions are connected with each other, and a list of suggested accommodations they can use in treatment. |
Timeline
- Start date
- 2026-04-28
- Primary completion
- 2030-01-01
- Completion
- 2030-07-31
- First posted
- 2025-10-10
- Last updated
- 2026-04-16
Source: ClinicalTrials.gov record NCT07215221. Inclusion in this directory is not an endorsement.